No Data
No Data
CCORF Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $62
Wall Street Analysts Are Bullish on Top Healthcare Picks
Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Scholar Rock Charts High-Stakes Path to SMA Launch
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
